Pharmaceutical

Kyowa Kirin acquires Orchard Therapeutics for $477.6m

Kyowa Kirin has acquired Orchard Therapeutics, a developer of hematopoietic stem cell gene therapies, for an equity value of $477.6m.

Jan 25, 2024 - 18:00
Kyowa Kirin acquires Orchard Therapeutics for $477.6m
Kyowa Kirin has acquired Orchard Therapeutics, a developer of hematopoietic stem cell gene therapies, for an equity value of $477.6m.
Read the original article

Tags:

Previous Article

Evaxion Biotech to develop new vaccines for cancer

Next Article

Synnovation launches with $102m to advance therapy pipeline

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Why so few get screened for lung cancer, the deadliest cancer in the U.S.

Why so few get screened for lung cancer, the deadliest ...

Aug 19, 2023

Phare Bio receives ARPA-H funds for AI drug discovery platform

Phare Bio receives ARPA-H funds for AI drug discovery p...

Sep 28, 2024

Risk adjusted net present value: What is the current va...

Jul 2, 2024